Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Deal Watch: Xencor Adds New Bispecific Partner In Agreement With Genentech

Feb 06 2019

• By Joseph Haas and Jung Won Shin

DealWatch_1200x675

Related Content

Nupharm rebrands itself to Neuraxpharm

Oct 19 2018

In Dry Eye, A Variety Of Mechanisms Pursue Established Therapies

Jan 15 2018

Deal Watch: Celgene Makes Alliances With Kyn, Obsidian After Bristol Buyout

Jan 21 2019

MeiraGTx Signs J&J To Develop Gene Therapies For Rare Retinal Diseases

Jan 31 2019

Bristol Approached Celgene Nearly Two Years Ago, Got A Better Deal Later

Feb 01 2019

Medicxi Links With Sosei Heptares For Orexin Agonist Vehicles

Feb 05 2019

Simbec-Orion MBO Underpins Build And Buy Strategy

Feb 05 2019

GSK Makes I-O Move With Merck KGaA Deal Worth Up To €3.7bn

Feb 05 2019

Future Looks Bright For Ambitious Argenx

Aug 23 2018

Fortress Biotech: A Drug Financing Experiment Expands

Jun 13 2017

Voyager Nabs Neurocrine As Partner In CNS Gene Therapy

Jan 30 2019

Deal Watch: Sanofi Retains Options To Two Bispecifics While Exiting Antibody Pact With Regeneron

Jan 07 2019

Cullinan To Search For Oncology’s Diamonds In The Rough

Oct 03 2017

Related Companies

Pfizer Inc.

Merck KGaA

GSK plc

Nxera Pharma Co., Ltd.

MeiraGTx Holdings plc

Johnson & Johnson

Voyager Therapeutics, Inc

Novartis AG

Xencor, Inc.

Genentech, Inc.

Amgen, Inc.

Otsuka Holdings Co., Ltd.

Cullinan Therapeutics, Inc.

Triphase Accelerator Corporation

Bristol Myers Squibb Company

Bristol Myers Squibb Company

Obsidian Therapeutics, Inc.

Ikena Oncology

Alexion Pharmaceuticals Inc.

Fortress Biotech Inc.

Columbia University

Fortress Biotech Inc.

Neuraxpharm Arzneimittel GmbH

Qualigen Therapeutics, Inc.

FB Health S.p.A.

Aldeyra Therapeutics, Inc.

Aldeyra Therapeutics, Inc.

Halozyme Therapeutics, Inc.

argenx N.V.

scPharmaceuticals, Inc.

West Pharmaceutical Services, Inc.

Repare Therapeutics, Inc.

Ono Pharmaceutical Company, Ltd.

GC Biopharma Corp.

Harvard University

Massachusetts Eye & Ear Infirmary

Additional Topics

Deals Business Strategies M & A Commercial BioPharmaceutical

More from Deals

More from Business

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.